0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

Kevin Marsh/Malar J


15 results

Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial.Mzumara, G. Leopold, S. Marsh, K. Dondorp, A. Ohuma, E. O. Mukaka, M.
Malar J, (2021). 20:282

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.Ochola-Oyier, L. I. Okombo, J. Wagatua, N. Ochieng, J. Tetteh, K. K. Fegan, G. Bejon, P. Marsh, K.
Malar J, (2016). 15:261

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.Kangoye, D. T. Noor, A. Midega, J. Mwongeli, J. Mkabili, D. Mogeni, P. Kerubo, C. Akoo, P. Mwangangi, J. Drakeley, C. Marsh, K. Bejon, P. Njuguna, P.
Malar J, (2016). 15:213

Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.Shelton, J. M. Corran, P. Risley, P. Silva, N. Hubbart, C. Jeffreys, A. Rowlands, K. Craik, R. Cornelius, V. Hensmann, M. Molloy, S. Sepulveda, N. Clark, T. G. Band, G. Clarke, G. M. Spencer, C. C. Kerasidou, A. Campino, S. Auburn, S. Tall, A. Ly, A. B. Mercereau-Puijalon, O. Sakuntabhai, A. Djimde, A. Maiga, B. Toure, O. Doumbo, O. K. Dolo, A. Troye-Blomberg, M. Mangano, V. D. Verra, F. Modiano, D. Bougouma, E. Sirima, S. B. Ibrahim, M. Hussain, A. Eid, N. Elzein, A. Mohammed, H. Elhassan, A. Elhassan, I. Williams, T. N. Ndila, C. Macharia, A. Marsh, K. Manjurano, A. Reyburn, H. Lemnge, M. Ishengoma, D. Carter, R. Karunaweera, N. Fernando, D. Dewasurendra, R. Drakeley, C. J. Riley, E. M. Kwiatkowski, D. P. Rockett, K. A. Malaria, G. E. N. Consortium
Malar J, (2015). 14:333

Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.Hodgson, S. H. Juma, E. Salim, A. Magiri, C. Njenga, D. Molyneux, S. Njuguna, P. Awuondo, K. Lowe, B. Billingsley, P. F. Cole, A. O. Ogwang, C. Osier, F. Chilengi, R. Hoffman, S. L. Draper, S. J. Ogutu, B. Marsh, K.
Malar J, (2015). 14:182

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.Hodgson, S. H. Douglas, A. D. Edwards, N. J. Kimani, D. Elias, S. C. Chang, M. Daza, G. Seilie, A. M. Magiri, C. Muia, A. Juma, E. A. Cole, A. O. Rampling, T. W. Anagnostou, N. A. Gilbert, S. C. Hoffman, S. L. Draper, S. J. Bejon, P. Ogutu, B. Marsh, K. Hill, A. V. Murphy, S. C.
Malar J, (2015). 14:33

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.Vekemans, J. Marsh, K. Greenwood, B. Leach, A. Kabore, W. Soulanoudjingar, S. Asante, K. P. Ansong, D. Evans, J. Sacarlal, J. Bejon, P. Kamthunzi, P. Salim, N. Njuguna, P. Hamel, M. J. Otieno, W. Gesase, S. Schellenberg, D. Clinical Trials Partnership, Committee
Malar J, (2011). 10:221

Congenital and neonatal malaria in a rural Kenyan district hospital: an eight-year analysis.Mwaniki, M. K. Talbert, A. W. Mturi, F. N. Berkley, J. A. Kager, P. Marsh, K. Newton, C. R.
Malar J, (2010). 9:313

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.Kinyanjui, S. M. Bejon, P. Osier, F. H. Bull, P. C. Marsh, K.
Malar J, (2009). 8:242

Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolates.Blythe, J. E. Niang, M. Marsh, K. Holder, A. A. Langhorne, J. Preiser, P. R.
Malar J, (2009). 8:140

Chloroquine resistance before and after its withdrawal in Kenya.Mwai, L. Ochong, E. Abdirahman, A. Kiara, S. M. Ward, S. Kokwaro, G. Sasi, P. Marsh, K. Borrmann, S. Mackinnon, M. Nzila, A.
Malar J, (2009). 8:106

Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1.Mackintosh, C. L. Christodoulou, Z. Mwangi, T. W. Kortok, M. Pinches, R. Williams, T. N. Marsh, K. Newbold, C. I.
Malar J, (2008). 7:155

The decline in paediatric malaria admissions on the coast of Kenya.Okiro, E. A. Hay, S. I. Gikandi, P. W. Sharif, S. K. Noor, A. M. Peshu, N. Marsh, K. Snow, R. W.
Malar J, (2007). 6:151

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.Kinyanjui, S. M. Conway, D. J. Lanar, D. E. Marsh, K.
Malar J, (2007). 6:82

Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.Ochong, E. Nzila, A. Kimani, S. Kokwaro, G. Mutabingwa, T. Watkins, W. Marsh, K.
Malar J, (2003). 2:46